Evidence map›Paper›PMID 42217154›Full record

ReviewProbiotics and antimicrobial proteins2026

Bacillaceae in Probiotics and Postbiotics: Applications, Functional Traits, Mechanisms and Outlook.

Elvina Parlindungan, John En Song Luah, Mario Wibowo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elvina ParlindunganAgency for Science, Technology and Research (A*STAR), Singapore Institute of Food and Biotechnology Innovation (SIFBI), 31 Biopolis Way, Nanos, Singapore, 138669, Singapore. Elvina_Parlindungan@a-star.edu.sg.
John En Song LuahAgency for Science, Technology and Research (A*STAR), Singapore Institute of Food and Biotechnology Innovation (SIFBI), 31 Biopolis Way, Nanos, Singapore, 138669, Singapore.
Mario WibowoAgency for Science, Technology and Research (A*STAR), Singapore Institute of Food and Biotechnology Innovation (SIFBI), 31 Biopolis Way, Nanos, Singapore, 138669, Singapore.

Funding

Innovation & Enterprise (I&E), Agency for Science, Technology, and Research (A*STAR) I24D1AG061
6 · The paper itself

Abstract

Despite the well-documented health benefits of non-spore-forming probiotics such as Lactobacillus and Bifidobacterium, their broader application can be constrained by limited stability and survivability during processing, storage and gastrointestinal transit. These limitations have driven growing interest in spore-forming bacteria belonging to Bacillaceae family for potential use as probiotics particularly for products that require heat processing or extended shelf-life. This review focuses on the genera Bacillus, Heyndrickxia and Priestia, which have established roles across biotechnology, food and industrial applications, with evidence demonstrating benefits in plants, animals and human nutrition. Key technological traits, carbohydrates and nitrogen metabolism capacities and bioactive outputs are highlighted in this review, including the production of enzymes, antimicrobial compounds such as bacteriocins and non-ribosomal synthesized peptides, as well as other metabolites relevant to host and microbiome modulation. The mechanistic basis underpinning reported functions, such as competitive exclusions, antimicrobial activity, and immunomodulatory effect are also discussed in the context of probiotic and postbiotic. Finally, translational considerations, challenges and outlook in spore-forming probiotic and postbiotic biosolutions are addressed, including strain specific efficacy, safety evaluation and long-term use, and the practical requirements for robust human validation. This review intends to provide a critical and comprehensive synthesis, to update and further encourage researchers and industry stakeholders in developing Bacillaceae-based probiotics and postbiotics that align with the market needs.

Indexed as

BacillusHeyndrickxiaMetabolismPriestia

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.